121 related articles for article (PubMed ID: 35369963)
1. Heme peroxidases are responsible for the dehydrogenation and oxidation metabolism of harmaline into harmine.
Wang YX; Cao N; Guan HD; Cheng XM; Wang CH
Chin J Nat Med; 2022 Mar; 20(3):194-201. PubMed ID: 35369963
[TBL] [Abstract][Full Text] [Related]
2. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.
Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang C
Drug Test Anal; 2017 May; 9(5):754-768. PubMed ID: 27377954
[TBL] [Abstract][Full Text] [Related]
3. Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy.
Zhao T; Zheng SS; Zhang BF; Li YY; Bligh SW; Wang CH; Wang ZT
Food Chem; 2012 Sep; 134(2):1096-105. PubMed ID: 23107733
[TBL] [Abstract][Full Text] [Related]
4. Naturally-occurring tetrahydro-β-carboline alkaloids derived from tryptophan are oxidized to bioactive β-carboline alkaloids by heme peroxidases.
Herraiz T; Galisteo J
Biochem Biophys Res Commun; 2014 Aug; 451(1):42-7. PubMed ID: 25035927
[TBL] [Abstract][Full Text] [Related]
5. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine.
Yu AM; Idle JR; Krausz KW; Küpfer A; Gonzalez FJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):315-22. PubMed ID: 12649384
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of myeloperoxidase activity by the alkaloids of Peganum harmala L. (Zygophyllaceae).
Bensalem S; Soubhye J; Aldib I; Bournine L; Nguyen AT; Vanhaeverbeek M; Rousseau A; Boudjeltia KZ; Sarakbi A; Kauffmann JM; Nève J; Prévost M; Stévigny C; Maiza-Benabdesselam F; Bedjou F; Van Antwerpen P; Duez P
J Ethnopharmacol; 2014 Jun; 154(2):361-9. PubMed ID: 24746482
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and biotransformation of β-carboline alkaloids, harmine and harmaline, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Ishii H; Ogata A; Nakae D
Chem Biol Interact; 2010 Dec; 188(3):393-403. PubMed ID: 20833158
[TBL] [Abstract][Full Text] [Related]
8. Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection.
Moncrieff J
J Chromatogr; 1989 Nov; 496(2):269-78. PubMed ID: 2613832
[TBL] [Abstract][Full Text] [Related]
9. Exposure Characteristics of the Analogous β-Carboline Alkaloids Harmaline and Harmine Based on the Efflux Transporter of Multidrug Resistance Protein 2.
Li S; Zhang Y; Deng G; Wang Y; Qi S; Cheng X; Ma Y; Xie Y; Wang C
Front Pharmacol; 2017; 8():541. PubMed ID: 28871225
[TBL] [Abstract][Full Text] [Related]
10. Studies of the interaction of the fluorophores harmine and harmaline with calf thymus DNA.
Duportail G; Lami H
Biochim Biophys Acta; 1975 Aug; 402(1):20-30. PubMed ID: 1171699
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based pharmacokinetics-pharmacodynamics studies of harmine and harmaline on neurotransmitters regulatory effects in healthy rats: Challenge on monoamine oxidase and acetylcholinesterase inhibition.
Jiang B; Meng L; Zou N; Wang H; Li S; Huang L; Cheng X; Wang Z; Chen W; Wang C
Phytomedicine; 2019 Sep; 62():152967. PubMed ID: 31154274
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of harmine, harmaline and their metabolites harmol and harmalol in beagle dog plasma by UPLC-ESI-MS/MS and its application to a pharmacokinetic study.
Zhang L; Teng L; Gong C; Liu W; Cheng X; Gu S; Deng Z; Wang Z; Wang C
J Pharm Biomed Anal; 2013 Nov; 85():162-8. PubMed ID: 23948761
[TBL] [Abstract][Full Text] [Related]
13. PHARMACOKINETICS In the rat of the hallucinogenic alkaloids harmine and harmaline.
Zetler G; Back G; Iven H
Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(3):273-92. PubMed ID: 4282118
[No Abstract] [Full Text] [Related]
14. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
15. In-silico Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson's disease.
Banerjee R; Kumar M; Gaurav I; Thakur S; Thakur A; Singh K; Karak S; Das R; Chhabra M
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(3):250-263. PubMed ID: 33183209
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro.
Jiménez J; Riverón-Negrete L; Abdullaev F; Espinosa-Aguirre J; Rodríguez-Arnaiz R
Exp Toxicol Pathol; 2008 Aug; 60(4-5):381-9. PubMed ID: 18430551
[TBL] [Abstract][Full Text] [Related]
17. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases.
Herraiz T; Guillén H; Galisteo J
Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β-carboline alkaloids, harmine derivatives.
Zhao T; He YQ; Wang J; Ding KM; Wang CH; Wang ZT
Phytother Res; 2011 Nov; 25(11):1671-7. PubMed ID: 21433154
[TBL] [Abstract][Full Text] [Related]
19. Innovative spectrofluorometric method for determination of harmaline and harmine in different matrices.
Abdelazim AH; Algarni MA; Almalki AH
Sci Rep; 2023 Nov; 13(1):19951. PubMed ID: 37968310
[TBL] [Abstract][Full Text] [Related]
20. UV-light-driven photooxidation of harmaline catalyzed by riboflavin: Product characterization and mechanisms.
Sun CP; Yi J; Wei F; Lv X; Deng S; Zhang BJ; Zhao WY; Ma XC
Fitoterapia; 2021 Nov; 155():105054. PubMed ID: 34626737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
